BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 2413082)

  • 1. Membrane phenotypic studies in B cell lymphoproliferative disorders.
    Scott CS; Limbert HJ; MacKarill ID; Roberts BE
    J Clin Pathol; 1985 Sep; 38(9):995-1001. PubMed ID: 2413082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolymphocytoid variants of chronic lymphocytic leukaemia: an immunological and morphological survey.
    Scott CS; Limbert HJ; Roberts BE; Stark AN
    Leuk Res; 1987; 11(2):135-40. PubMed ID: 2950280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukaemia cells activated in vitro reveal cellular changes that characterize B-prolymphocytic leukaemia and immunocytoma.
    Robèrt KH; Juliusson G; Biberfeld P
    Scand J Immunol; 1983 May; 17(5):397-401. PubMed ID: 6602370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and modulation of common acute lymphoblastic leukaemia antigen by B prolymphocytic leukaemia cells.
    de Paoli P; Battistin S; Fantin O; Nimis R; Reitano M; Santini G
    Immunol Lett; 1985; 9(5):263-6. PubMed ID: 3158600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2 phenotypic variants of B-cell lymphocytic leukemia].
    Merson AG; Brosh'e Zh; Gipsh NM; Karminskaia NM; Udris OIu
    Eksp Onkol; 1988; 10(1):40-3. PubMed ID: 3259500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization.
    Delia D; Cattoretti G; Bonati A; Villa S; De Braud F; Buscaglia M
    Clin Exp Immunol; 1985 Feb; 59(2):305-14. PubMed ID: 2579752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolymphocytoid transformation of CLL: a clinical and immunological study of 22 cases.
    Stark AN; Limbert HJ; Roberts BE; Jones RA; Scott CS
    Leuk Res; 1986; 10(10):1225-32. PubMed ID: 3534474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
    Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
    Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current concepts in immunology: Cell-surface markers in lymphoproliferative disease.
    Aisenberg AC
    N Engl J Med; 1981 Feb; 304(6):331-6. PubMed ID: 6969365
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactivity of the monoclonal antibody RFB1 in chronic B-cell leukaemias.
    Melo JV; Catovsky D; Bodger M
    Scand J Haematol; 1984 Apr; 32(4):417-22. PubMed ID: 6609424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg).
    Kimby E; Axelsson B; Björkholm M; Gordon J; Holm G; Mellstedt H
    Med Oncol Tumor Pharmacother; 1985; 2(4):261-7. PubMed ID: 2935687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The presence of CALLA (common acute lymphoblastic leukemia antigens) and B-cell differentiation antigens in lymphocytic lymphoma].
    Jarczok K; Hołowiecki J; Stańczuk M; Hołowiecka B; Krawczyk-Kuliś M
    Pol Tyg Lek; 1984 Sep; 39(36):1197-9. PubMed ID: 6239146
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoperoxidase staining of surface and intracellular immunoglobulin in human neoplastic lymphoid cells.
    Mason DY; Leonard RC; Laurent G; Gourdin MF
    J Clin Pathol; 1980 Jul; 33(7):609-16. PubMed ID: 7000833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique epitopes of common acute lymphoblastic leukemia antigen detected by new monoclonal antibodies.
    Matsuzaki H; Haruta Y; Fukukawa T; Barcos MP; Seon BK
    Cancer Res; 1987 Apr; 47(8):2160-6. PubMed ID: 2435407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.
    Cossman J; Neckers LM; Hsu S; Longo D; Jaffe ES
    Am J Pathol; 1984 Apr; 115(1):117-24. PubMed ID: 6201073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic analysis of acute lymphoblastic leukemia (ALL) cells which are classified as non-T non-B and negative for common ALL antigen.
    Kita K; Nasu K; Kamesaki H; Doi S; Tezuka H; Tatsumi E; Fukuhara S; Nishikori M; Uchino H; Shirakawa S
    Blood; 1985 Jul; 66(1):47-52. PubMed ID: 3159446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of membrane marker phenotypes in hairy-cell leukemia and phorbol-ester induced B-cll cells using monoclonal antibodies.
    Herrmann F; Dörken B; Ludwig WD; Schwarting R
    Leuk Res; 1985; 9(5):529-36. PubMed ID: 2409407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal immunoglobulins and B cell lymphoproliferative disorders.
    Sugai S; Takiguchi T; Konda S
    Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1604-15. PubMed ID: 6335808
    [No Abstract]   [Full Text] [Related]  

  • 20. The reproducibility of acute lymphoblastic leukemia phenotype determinations: evaluation of monoclonal antibody and conventional hematopoietic markers.
    Sobol RE; Mick R; LeBien TW; Ozer H; Minowada J; Anderson K; Ellison RR; Cuttner J; Morrison A; Richards F
    Leuk Res; 1986; 10(5):481-5. PubMed ID: 2940420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.